4-氨基吡啶——一种用于伊顿-兰伯特综合征治疗试验的新药。
4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.
作者信息
Lundh H, Nilsson O, Rosén I
出版信息
J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1109-12. doi: 10.1136/jnnp.40.11.1109.
Abstract
A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.
摘要
一名患有与小细胞支气管肺癌相关的肌无力综合征的67岁男性接受了一种新药4-氨基吡啶的治疗。肌无力症状明显改善，电生理检查显示神经肌肉传递功能恢复。
相似文献
1
4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.4-氨基吡啶——一种用于伊顿-兰伯特综合征治疗试验的新药。
J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1109-12. doi: 10.1136/jnnp.40.11.1109.
2
The influence of local cooling on neuromuscular transmission in the myasthenic syndrome of Eaton and Lambert.局部冷却对伊顿-兰伯特肌无力综合征神经肌肉传递的影响。
J Neurol. 1977 Dec 13;217(2):95-102. doi: 10.1007/BF00312922.
3
4
Treatment for Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征的治疗。
Cochrane Database Syst Rev. 2003(2):CD003279. doi: 10.1002/14651858.CD003279.
5
Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.静脉注射免疫球蛋白对合并小细胞肺癌的兰伯特-伊顿肌无力综合征的影响：与抗电压门控钙通道抗体滴度的相关性
Muscle Nerve. 1994 Sep;17(9):1073-5. doi: 10.1002/mus.880170919.
6
Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.一名小细胞肺癌患者的兰伯特-伊顿肌无力综合征
Clin Lung Cancer. 2006 Jan;7(4):282-4. doi: 10.3816/CLC.2006.n.008.
7
Congenital Lambert-Eaton myasthenic syndrome.先天性兰伯特-伊顿肌无力综合征
J Neurol Neurosurg Psychiatry. 1987 Apr;50(4):476-8. doi: 10.1136/jnnp.50.4.476.
8
Eaton-Lambert myasthenic syndrome: two cases with typical and atypical features.伊顿-兰伯特肌无力综合征：两例具有典型和非典型特征的病例。
N Z Med J. 1990 May 23;103(890):240-2.
9
Effects of 4-aminopyridine in Eaton Lambert Syndrome.4-氨基吡啶对伊顿-兰伯特综合征的影响。
Br J Anaesth. 1978 Apr;50(4):383-5. doi: 10.1093/bja/50.4.383.
10
Guanidine hydrochloride in the Eaton-Lambert syndrome. Electrophysiologic improvement.伊顿-兰伯特综合征中的盐酸胍。电生理改善。
Neurology. 1973 Oct;23(10):1084-90. doi: 10.1212/wnl.23.10.1084.
引用本文的文献
1
Amifampridines are the Most Effective Drugs for Treating Lambert-Eaton Myasthenic Syndrome With a Focus on Pediatric Lambert-Eaton Myasthenic Syndrome.氨吡啶类药物是治疗兰伯特-伊顿肌无力综合征最有效的药物，重点关注儿童兰伯特-伊顿肌无力综合征。
J Clin Neurol. 2024 Jul;20(4):353-361. doi: 10.3988/jcn.2024.0018.
2
Pharmacological Attenuation of Electrical Effects in a Model of Compression Neuropathy.药理学减轻压迫性神经病变模型中的电效应。
J Bone Joint Surg Am. 2019 Mar 20;101(6):523-530. doi: 10.2106/JBJS.18.00162.
3
4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury.4-氨基吡啶可促进急性周围神经损伤后的功能恢复和髓鞘再生。
EMBO Mol Med. 2016 Dec 1;8(12):1409-1420. doi: 10.15252/emmm.201506035. Print 2016 Dec.
4
Treatment for Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征的治疗。
Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003279. doi: 10.1002/14651858.CD003279.pub3.
5
The use of 4-aminopyridine (fampridine) in demyelinating disorders.4-氨基吡啶（法吡拉定）在脱髓鞘疾病中的应用。
CNS Drug Rev. 2004 Winter;10(4):295-316. doi: 10.1111/j.1527-3458.2004.tb00029.x.
6
Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease.4-氨基吡啶对犬运动神经元疾病中肌肉和运动单位力量的影响。
J Neurosci. 1997 Jun 1;17(11):4500-7. doi: 10.1523/JNEUROSCI.17-11-04500.1997.
7
3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome.3,4-二氨基吡啶，一种孤儿药，用于兰伯特-伊顿肌无力综合征的对症治疗。
Pflugers Arch. 1996;431(6 Suppl 2):R295-6. doi: 10.1007/BF02346385.
8
Delayed depolarization and slow sodium currents in cutaneous afferents.皮肤传入神经中的延迟去极化和缓慢钠电流。
J Neurophysiol. 1994 May;71(5):1627-37. doi: 10.1152/jn.1994.71.5.1627.
9
The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.4-氨基吡啶和四乙铵离子对正常及脱髓鞘哺乳动物神经纤维的影响。
J Physiol. 1981;313:301-15. doi: 10.1113/jphysiol.1981.sp013666.
10
Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.伊顿-兰伯特综合征：一例接受4-氨基吡啶治疗患者的临床与电生理研究。
J Neurol Neurosurg Psychiatry. 1980 Nov;43(11):978-85. doi: 10.1136/jnnp.43.11.978.
本文引用的文献
1
Defects of neuromuscular transmission in syndromes other than myasthenia gravis.重症肌无力以外综合征中的神经肌肉传递缺陷。
Ann N Y Acad Sci. 1966 Jan 26;135(1):367-84. doi: 10.1111/j.1749-6632.1966.tb45484.x.
2
[Pharmacological approach to the study of convulsive action mechanism of amino-4 pyridine].[4-氨基吡啶惊厥作用机制研究的药理学方法]
Therapie. 1971 Sep-Oct;26(5):927-40.
3
4
Guanidine and germine in Eaton-Lambert syndrome.伊顿-兰伯特综合征中的胍和胚芽碱。
Neurology. 1976 Oct;26(10):944-6. doi: 10.1212/wnl.26.10.944.
5
Clinical, neurophysiological and morphological findings in Eaton Lambert syndrome.伊顿-兰伯特综合征的临床、神经生理学及形态学表现
Acta Neurol Scand. 1977 Aug;56(2):117-40. doi: 10.1111/j.1600-0404.1977.tb01417.x.
6
Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine.肉毒杆菌毒素所致大鼠麻痹的拮抗作用。四乙铵、胍和4-氨基吡啶的作用。
J Neurol Sci. 1977 May;32(1):29-43. doi: 10.1016/0022-510x(77)90037-5.
7
The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.4-氨基吡啶和胍对运动神经末梢递质释放的作用方式。
Eur J Pharmacol. 1977 Apr 21;42(4):411-2. doi: 10.1016/0014-2999(77)90176-5.
Zotero 插件